Levetiracetam Tablet, Film Coated
Product Images NDC 50090-7804

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-7804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a table showing the distribution of participants in a study based on the dosage of Levetiracetam tablets and Placebo. Participants were divided into three groups: Placebo (N=85), Levetiracetam Tablet 1000 mg/day (N=97), and Levetiracetam Tablet 3000 mg/day (N=101).*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

This text provides information about the percentage of patients for two different groups, including a placebo group and a group taking tam 3000 mg/day. The percentages are 10.4% and 39.4%, respectively. The sample sizes for the two groups are mentioned as N=104 for the placebo group and N=150 for the other group.*

FDA Label Image

Figure4 (Figure4)

This is a comparison table showing the percentage values for different groups. It includes a placebo group (N=97) and a group treated with Levetiracetam tablets (N=101). The percentages in the table range from 45% to 446%.*

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Label Image (Lbl500907804)

Not available.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.